Georgina S Daher-Reyes - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Georgina S Daher-Reyes

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Expert Opinion on Investigational Drugs|September 13, 2019

Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemiaGeorgina S Daher-Reyes, Brayan M Merchan, Karen W L Yee

Clinical Lymphoma, Myeloma & Leukemia|July 31, 2025

Identifying Risk Factors and Outcome for CNS Involvement in AMLJack T Seki, Georgina S Daher-Reyes, Eshetu G Atenafu, et al.

Blood Advances|August 3, 2019

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AMLTracy Murphy, Jinfeng Zou, Georgina S Daher-Reyes, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Expert Opinion on Investigational Drugs|September 13, 2019

Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemiaGeorgina S Daher-Reyes, Brayan M Merchan, Karen W L Yee

Clinical Lymphoma, Myeloma & Leukemia|July 31, 2025

Identifying Risk Factors and Outcome for CNS Involvement in AMLJack T Seki, Georgina S Daher-Reyes, Eshetu G Atenafu, et al.

Blood Advances|August 3, 2019

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AMLTracy Murphy, Jinfeng Zou, Georgina S Daher-Reyes, et al.

Pageof 1